+ All Categories
Home > Documents > Primary Prevention of Diabetes Update 2011

Primary Prevention of Diabetes Update 2011

Date post: 05-Apr-2018
Category:
Upload: putri-adimukti-mudjiono
View: 221 times
Download: 0 times
Share this document with a friend

of 18

Transcript
  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    1/18

    LIFE STYLE INTERVENTION

    HIGHLIGHTS

    DIABETES UPDATE 2011

    DIABETES CARE VOLUME 34 SUPPLEMENT 1 JANUARY 2011

    care.diabetesjournals.orgAmerican Diabetes AssociationPresentator : dr. Putri Adimukti, M.kes

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    2/18

    Current criteria for the

    diagnosis of diabetes

    A1C 6.5%.

    fasting plasma glucose (FPG) 126 mg/dl(7.0 mmol/l), or 2-h plasma glucose 200

    mg/dl (11.1 mmol/l)

    in a patient with classic symptoms ofhyperglycemia or hyperglycemic crisis,

    a random plasma glucose 200 mg/dl(11.1 mmol/l)

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    3/18

    Current criteria for the

    diagnosis of diabetesPrediabetes

    FPG 100125 mg/dl (5.66.9 mmol/l): IFG

    or

    2-h plasma glucose in the 75-g OGTT 140199mg/dl (7.811.0 mmol/l): IGT

    or

    A1C 5.76.4%

    Notice:

    FPG=Fasting Plasma Glucose

    IFG=Impaired Fasting Glucose

    IGT=Impaired Glucose Tolerance

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    4/18

    Risk Factor For Diabetes

    Overweight (BMI 25 Kg/m2), with additionalfactors:

    Physical inactivity

    First-degree relative with diabetes

    High-risk race/ethnicity (e.g., African American, Latino,Native American, Asian American, Pacific Islander)

    Women who delivered a baby weighing 9 lb or werediagnosed with GDM

    Hypertension (140/90 mmHg or on therapy forhypertension)

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    5/18

    Risk Factor For Diabetes

    HDL cholesterol level 35 mg/dl (0.90 mmol/l)

    Triglyceride level 250 mg/dl (2.82 mmol/l)

    Women with polycystic ovarian syndrome(PCOS)

    A1C 5.7%

    IGT, or IFG on previous testing

    Other clinical conditions associated with insulinresistance (e.g., severe obesity, acanthosisnigricans)

    History of CVD

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    6/18

    Testing for diabetes in

    asymptomatic patients

    In adults of any agewho are overweight or

    obese (BMI 25 kg/m2)and who have one ormore additional riskfactors for diabetes.

    In those without

    these risk factors,testing should begin

    at age 45 years.

    If tests are normal,repeat testing carriedout at least at 3-year

    intervals isreasonable.

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    7/18

    Prevention Prediabetes To

    Diabetes

    Patientswith:

    impairedglucosetolerance

    (IGT)

    impairedfasting

    glucose(IFG)

    A1C of5.76.4%

    should bereferred

    to aneffectiveongoing

    supportprogram

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    8/18

    Support Program

    weight loss of 7% of body weight

    increasing physical activity to at least 150min/week of moderate activity such as walking.

    Follow-up counseling appears to be importantfor success.

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    9/18

    Support Program

    Metformin therapy for prevention of type 2diabetes may be considered in :

    those at highest risk for developing diabetes, such as thosewith multiple risk factors, especially if they demonstrateprogression of hyperglycemia (e.g. A1C 6%).

    Monitoring for the development of diabetes inthose with prediabetes should be performedevery year.

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    10/18

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    11/18

    Macronutrients In

    Diabetes Management

    The best mix ofcarbohydrate,

    protein, and fatmay be adjusted to

    meet themetabolic goals

    Monitoringcarbohydrate,

    whether bycarbohydrate

    counting, choices,or experience-

    based estimation

    Use of glycemic

    index and glycemicload may provide amodest additional

    benefit forglycemic control

    Saturated fatintake should be

    7% or less of totalcalories.

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    12/18

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    13/18

    Physical Activity In Diabetes

    ManagementPeople with diabetes should be advised toperform at least 150 min/week of moderate-

    intensity aerobic physical activity (5070% ofmaximum heart rate).

    In the absence of contraindications, peoplewith type 2 diabetes should be encouragedto perform resistance training three timesper week.

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    14/18

    Dyslipidemia Screening

    In most adult patients, measurefasting lipid profile at least annually.

    Goals:

    LDL cholesterol 100 mg/dl

    HDL cholesterol 50 mg/dl

    Triglycerides 150 mg/dl)

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    15/18

    Goals

    Intensive lifestyle interventionresulted in

    Average 8.6% weight loss

    Significant reduction of A1C

    Reduction in several CVD risk factors

    Benefits sustained at 4 years

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    16/18

    Goals

    A1C

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    17/18

    Correlation of A1C with

    Estimated Average Glucose(eAG) Mean plasma glucose

    A1C (%) mg/dl mmol/l

    6 126 7.0

    7 154 8.6

    8 183 10.2

    9 212 11.8

    10 240 13.411 269 14.9

    12 298 16.5

  • 7/31/2019 Primary Prevention of Diabetes Update 2011

    18/18


Recommended